99 related articles for article (PubMed ID: 30190474)
1. Fumarate hydratase loss promotes mitotic entry in the presence of DNA damage after ionising radiation.
Johnson TI; Costa ASH; Ferguson AN; Frezza C
Cell Death Dis; 2018 Sep; 9(9):913. PubMed ID: 30190474
[TBL] [Abstract][Full Text] [Related]
2. Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism.
Valcarcel-Jimenez L; Frezza C
Br J Cancer; 2023 Nov; 129(10):1546-1557. PubMed ID: 37689804
[TBL] [Abstract][Full Text] [Related]
3. In deep bioinformatic characterization of a novel fumarate hydratase variant FH c.199T > G; (p.Tyr67Asp) in hereditary leiomyomatosis and renal cell carcinoma.
Chami A; de Souza Zózimo TR; Alves TM; Matosinho CGR; Santos C; Simões MM; Cabral WLR; de Paula Ricardo BF; da Silva Filho AL; Carvalho MRS; da Conceição Braga L
Fam Cancer; 2023 Oct; 22(4):481-486. PubMed ID: 37316640
[TBL] [Abstract][Full Text] [Related]
4. The clinicopathologic and molecular features, and treatment outcome of fumarate hydratase-deficient renal cell carcinoma: a retrospective comparison with type 2 papillary renal cell carcinoma.
Bai J; Li X; Wen Y; Lu Q; Chen R; Liu R; Shangguan T; Ye Y; Lin J; Cai W; Kang D; Chen J
Aging (Albany NY); 2024 Feb; 16(4):3631-3646. PubMed ID: 38376408
[TBL] [Abstract][Full Text] [Related]
5. Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair.
Sulkowski PL; Sundaram RK; Oeck S; Corso CD; Liu Y; Noorbakhsh S; Niger M; Boeke M; Ueno D; Kalathil AN; Bao X; Li J; Shuch B; Bindra RS; Glazer PM
Nat Genet; 2018 Aug; 50(8):1086-1092. PubMed ID: 30013182
[TBL] [Abstract][Full Text] [Related]
6. Could fumarate hydratase germline mutation in cutaneous leiomyomas predict Hereditary Leiomyoma and Renal Cell Cancer (HLRCC)?
You FR; Lai HJ; Yang L; Guo HW
Asian J Surg; 2023 Dec; 46(12):5531-5532. PubMed ID: 37591757
[No Abstract] [Full Text] [Related]
7. Hereditary leiomyomatosis and renal cell cancer linked with FH mutations.
Millington GWM
Clin Exp Dermatol; 2023 Oct; 48(11):1301-1303. PubMed ID: 37421326
[No Abstract] [Full Text] [Related]
8. FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer.
Wilde BR; Chakraborty N; Matulionis N; Hernandez S; Ueno D; Gee ME; Esplin ED; Ouyang K; Nykamp K; Shuch B; Christofk HR
Cancer Discov; 2023 Sep; 13(9):2072-2089. PubMed ID: 37255402
[TBL] [Abstract][Full Text] [Related]
9. Inherited skin tumour syndromes.
Brown S; Brennan P; Rajan N
Clin Med (Lond); 2017 Dec; 17(6):562-567. PubMed ID: 29196359
[TBL] [Abstract][Full Text] [Related]
10. Identification of Activators of Human Fumarate Hydratase by Quantitative High-Throughput Screening.
Zhu H; Lee OW; Shah P; Jadhav A; Xu X; Patnaik S; Shen M; Hall MD
SLAS Discov; 2020 Jan; 25(1):43-56. PubMed ID: 31522598
[TBL] [Abstract][Full Text] [Related]
11. Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma.
Fitzsimmons CM; Mandler MD; Lunger JC; Chan D; Maligireddy SS; Schmiechen AC; Gamage ST; Link C; Jenkins LM; Chan K; Andresson T; Crooks DR; Meier JL; Linehan WM; Batista PJ
NAR Cancer; 2024 Mar; 6(1):zcae004. PubMed ID: 38328795
[TBL] [Abstract][Full Text] [Related]
12. Conditional Covalent Lethality Driven by Oncometabolite Accumulation.
Perez M; Nance KD; Bak DW; Thalalla Gamage S; Najera SS; Conte AN; Linehan WM; Weerapana E; Meier JL
ACS Chem Biol; 2022 Oct; 17(10):2789-2800. PubMed ID: 36190452
[TBL] [Abstract][Full Text] [Related]
13. DCLRE1B/Apollo germline mutations associated with renal cell carcinoma impair telomere protection.
Bories C; Lejour T; Adolphe F; Kermasson L; Couvé S; Tanguy L; Luszczewska G; Watzky M; Poillerat V; Garnier P; Groisman R; Ferlicot S; Richard S; Saparbaev M; Revy P; Gad S; Renaud F
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167107. PubMed ID: 38430974
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the detection rate of fumarate peak in
Pan S; Wang J; Liu G; Zhang J; Song Y; Kong W; Zhou Y; Wu G
Clin Radiol; 2024 Jan; 79(1):e80-e88. PubMed ID: 37923625
[TBL] [Abstract][Full Text] [Related]
15. Improving Systemic Therapy for Fumarate Hydratase-deficient Renal Cell Carcinoma.
Carlo MI
Eur Urol; 2023 Apr; 83(4):e113-e114. PubMed ID: 36682904
[No Abstract] [Full Text] [Related]
16. MiR-223-3p promotes genomic stability of hematopoietic progenitors after radiation.
Chen S; Srinivasan G; Jaiswal A; Williamson EA; Li L; Arris D; Zhou D; Xu M; Hromas R
Exp Hematol; 2024 Jan; 129():104123. PubMed ID: 37875176
[TBL] [Abstract][Full Text] [Related]
17. Genetically driven predisposition leads to an unusually genomic unstable renal cell carcinoma.
Scimeca M; Rovella V; Caporali S; Shi Y; Bischof J; Woodsmith J; Tisone G; Sica G; Amelio I; Melino G; Mauriello A; Bove P
Discov Oncol; 2024 Mar; 15(1):80. PubMed ID: 38512353
[TBL] [Abstract][Full Text] [Related]
18. Sporadic fumarate hydratase-deficient cutaneous leiomyomatosis.
Zhang SX; Banta JC; Lee CM
J Cutan Pathol; 2024 Mar; 51(3):177-180. PubMed ID: 37944595
[No Abstract] [Full Text] [Related]
19. Corrigendum to "Post-translational regulation of metabolism in fumarate hydratase deficient cancer cells" [Metabol. Eng. 45 (2018) 149-157].
Gonçalves E; Sciacovelli M; Costa ASH; Tran MGB; Johnson TI; Machado D; Frezza C; Saez-Rodriguez J
Metab Eng; 2024 Mar; 82():297-298. PubMed ID: 38245482
[No Abstract] [Full Text] [Related]
20. Fumarate hydratase: a new checkpoint of metabolic regulation in inflammatory macrophages.
Jeridi A; Kapellos TS; Yildirim AÖ
Signal Transduct Target Ther; 2023 Sep; 8(1):332. PubMed ID: 37666844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
